How Psychedelics Affect the Brain www.nytimes.com/2026/04/07/h...
Psychedelics may weaken the normal flow of information into higher-order systems that support abstract self-referential processing, allowing perception and cognition to become less constrained. An interesting systems neuroscience account of psychedelic action.
This 👇is the last revolution. We are working on the next one - and need your help.
HIRING: Postdoc at NYU (Center for Psychedelic Medicine). Looking for strong neuroimaging, human subjects experience, a publication track record, and top scientistiness.
Send CV to [email protected]
What matters most for childhood brain organization?
We analyzed 649 variables.
The answer: Socioeconomics (SES); with brain patterns pointing at sleep & stress as drivers.
Even brain-IQ associations were better explained by SES.
In Science today: www.science.org/doi/10.1126/...
Excited to see this out in PNAS. A fabulous project by Adam Pines and the Williams lab: across psychedelics (LSD, Psilo, MDMA), species, and datasets, a very consistent story—reduced propagation of activity into the default mode network (DMN). Congrats Adam! 🧠🍄
www.pnas.org/doi/10.1073/...
The big questions facing psychedelic science:
1. What’s the biology of psychedelic experiences?
2. Is the experience necessary for clinical benefit?
3. How do we solve expectancy+unblinding in trials?
We synthesize what we know and the big Qs in a Nature Med Review:
nature.com/articles/s41...
What an awesome opportunity!
* working with Josh Siegel
* working on psychodelics
* working in NYC
Psychedelic drugs are poised to become mainstream treatments, yet we lack a circuit-level
account of how they reshape brain activity. Emerging evid...
Parkinson's disease affects over 10 million people worldwide. A new study led by WashU Medicine researchers is paving the way for more personalized, non-invasive treatment, tackling this neurological disorder at its root. @ndosenbach.bsky.social medicine.washu.edu/news/brain-n...
It’s time to rethink Parkinson’s disease. Our work reframes PD as a disorder of the somato-cognitive action network (SCAN), and shows that normalizing SCAN connectivity represents a shared mechanism across diverse effective therapies.
rdcu.be/e2n4t
@ndosenbach.bsky.social @gordonneuro.bsky.social
